Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Nosopharm team identifies new class of antibiotics

Researchers at Nosopharm S.A.S. (Nimes, France) and academic colleagues identified a previously unknown class of naturally produced antibiotics that binds to a new site within the bacterial ribosome's decoding center and induces miscoding, killing the bacteria.

Previous

Read the full 362 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE